Redoxis AB

Redoxis AB

Verified
Redoxis is a preclinical CRO with focus on inflammation and autoimmune conditions

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues1m<1m<1m1m1m--
% growth-(30 %)(14 %)67 %---
EBITDA<1m<1m<1m<1m<1m--
% EBITDA margin30 %29 %5 %20 %20 %--
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
€360kGrant
N/AGrant
Not yet verified
Total Funding$396k

Recent News about Redoxis AB

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.